These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 2930150

  • 1. [Anti-arrhythmia efficacy of propafenone per os in the prevention of paroxysmal supraventricular arrhythmia resistant to class Ia agents].
    Boutaud P, Guillem JP, Maarek-Charbit M, Amiel A, Ciber M, Herpin D, Demange J.
    Ann Cardiol Angeiol (Paris); 1989 Jan; 38(1):37-42. PubMed ID: 2930150
    [Abstract] [Full Text] [Related]

  • 2. A randomized, placebo-controlled trial of propafenone in the prophylaxis of paroxysmal supraventricular tachycardia and paroxysmal atrial fibrillation. UK Propafenone PSVT Study Group.
    Circulation; 1995 Nov 01; 92(9):2550-7. PubMed ID: 7586356
    [Abstract] [Full Text] [Related]

  • 3. [The efficacy of propafenon in the case of supraventricular atrioventricular tachycardia].
    Chachua T, Abuladze G, Nebieridze M.
    Georgian Med News; 2010 Jun 01; (183):18-21. PubMed ID: 20622270
    [Abstract] [Full Text] [Related]

  • 4. [Anti-arrhythmic effect of oral propafenone. Apropos of 70 cases].
    Coumel P, Leclercq JF, Assayag P, Maisonblanche P, Cauchemez B.
    Arch Mal Coeur Vaiss; 1984 Nov 01; 77(12):1370-82. PubMed ID: 6439161
    [Abstract] [Full Text] [Related]

  • 5. [Cibenzoline versus propafenone by the oral route for preventing recurrence of atrial arrhythmia: multicenter, randomized, double-blind study].
    Lardoux H, Maison Blanche P, Marchand X, Canler A, Rouesnel P, Bleinc D, Péraudeau P, Scheck F.
    Ann Cardiol Angeiol (Paris); 1996 Oct 01; 45(8):469-79. PubMed ID: 8952741
    [Abstract] [Full Text] [Related]

  • 6. [Supraventricular tachycardia with wide QRS complexes during Vaughan-Williams class I anti-arrhythmic treatment. Diagnostic and therapeutic implications].
    Aouate P, Frank R, Fontaine G, Tonet J, Tageddine R, Benassar A, Turlure A, Jacquemin M, Laborde JP.
    Arch Mal Coeur Vaiss; 1995 Dec 01; 88(12):1869-74. PubMed ID: 8729368
    [Abstract] [Full Text] [Related]

  • 7. [Intravenous and oral propafenone in the treatment and prevention of paroxysmal atrial fibrillation].
    Cointe R, Metge M, Bru P, Vrancea F, Gerard R, Paganelli F, Lévy S.
    Ann Cardiol Angeiol (Paris); 1993 Apr 01; 42(4):223-7. PubMed ID: 8517602
    [Abstract] [Full Text] [Related]

  • 8. Ibutilide added to propafenone for the conversion of atrial fibrillation and atrial flutter.
    Chiladakis JA, Kalogeropoulos A, Patsouras N, Manolis AS.
    J Am Coll Cardiol; 2004 Aug 18; 44(4):859-63. PubMed ID: 15312872
    [Abstract] [Full Text] [Related]

  • 9. [Use of propafenone in emergency therapy].
    Liguori A, Pellegrino G, Di Ieso N, Piatto A, Ruggiero P, Scarnera P, Guardascione A.
    Clin Ter; 1989 Dec 15; 131(5):307-14. PubMed ID: 2532584
    [Abstract] [Full Text] [Related]

  • 10. [The treatment of arrhythmias in infants and children using propafenone].
    Dressler F, Grävinghoff L, Grütte E, Jüngst BK, Liersch R, Nomayo H, Puls I, Rautenburg HW, Schmaltz A, Schumacher G.
    Monatsschr Kinderheilkd; 1985 Mar 15; 133(3):154-7. PubMed ID: 4010670
    [Abstract] [Full Text] [Related]

  • 11. [Efficacy of intravenous Acehytisine Hydrochloride versus propafenone on terminating paroxysmal supraventricular tachycardia: a double-blinded, randomized multi-center study].
    Gao X, Zhu J, Yang YM, Li JD, Yang ZM, Liu JH, Acehytisine Hydrochloride Injection Phase II Clinic Trial Group Investigators.
    Zhonghua Xin Xue Guan Bing Za Zhi; 2007 Feb 15; 35(2):151-4. PubMed ID: 17445412
    [Abstract] [Full Text] [Related]

  • 12. Propafenone treatment of symptomatic paroxysmal supraventricular arrhythmias. A randomized, placebo-controlled, crossover trial in patients tolerating oral therapy.
    Pritchett EL, McCarthy EA, Wilkinson WE.
    Ann Intern Med; 1991 Apr 01; 114(7):539-44. PubMed ID: 2001087
    [Abstract] [Full Text] [Related]

  • 13. Paroxysmal supraventricular tachycardia: experience with propafenone.
    Santinelli V, De Paola M, Turco P, Smimmo D, Chiariello M.
    Angiology; 1989 Jun 01; 40(6):563-8. PubMed ID: 2719341
    [Abstract] [Full Text] [Related]

  • 14. [Pharmacokinetics of oral propafenone in patients with supraventricular arrhythmia].
    Buoncuore A, Poirier JM, Jaillon P, Ferry A, Pochmalicki G, Colombel B, Vrancea F, Cheymol G, Valty J.
    Therapie; 1989 Jun 01; 44(2):79-85. PubMed ID: 2756523
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the efficacy of propafenone versus disopyramide for complex premature ventricular contractions. Evaluation with long-term monitoring.
    Naccarella F, Palmieri M, del Corso P, Lombardi G, Bracchetti D.
    Arzneimittelforschung; 1982 Jun 01; 32(5):547-50. PubMed ID: 7201833
    [Abstract] [Full Text] [Related]

  • 16. [Anti-arrhythmia efficacy of propafenone in children. Apropos of 30 cases].
    Lucet V, Do Ngoc D, Fidelle J, Sidi D, Batisse A, Loth P, Vrancea F, Villain E, Coumel P.
    Arch Mal Coeur Vaiss; 1987 Aug 01; 80(9):1385-93. PubMed ID: 3122689
    [Abstract] [Full Text] [Related]

  • 17. Efficacy and safety of dofetilide in the prevention of symptomatic episodes of paroxysmal supraventricular tachycardia: a 6-month double-blind comparison with propafenone and placebo.
    Tendera M, Wnuk-Wojnar AM, Kulakowski P, Malolepszy J, Kozlowski JW, Krzeminska-Pakula M, Szechinski J, Droszcz W, Kawecka-Jaszcz K, Swiatecka G, Ruzyllo W, Graff O.
    Am Heart J; 2001 Jul 01; 142(1):93-8. PubMed ID: 11431663
    [Abstract] [Full Text] [Related]

  • 18. [Propafenone efficacy in preventing supraventricular tachycardia in childhood].
    Bodegas A, Cabrera A, Sarrionaindía MJ, Idígoras G, Rumoroso JR, Pérez García P, Pastor E, Galdeano JM, Sota J, Barrenetxea JI.
    Rev Esp Cardiol; 1994 Feb 01; 47(2):86-91. PubMed ID: 8165353
    [Abstract] [Full Text] [Related]

  • 19. [Oral propafenone in resistant auricular arrhythmia].
    Bounhoure JP, Sabot G, Cassagneau B, Calazel J, Dechandol AM.
    Ann Cardiol Angeiol (Paris); 1985 Feb 01; 34(7):485-8. PubMed ID: 4062207
    [Abstract] [Full Text] [Related]

  • 20. [Comparison of efficacy, safety and cost-effectiveness of intravenous versus oral propafenone in paroxysmal atrial fibrillation].
    Zadura M, Grossmann G, Modrzewska A, Klecha T, Klepacka H, Rumiński W.
    Pol Merkur Lekarski; 2001 Aug 01; 11(62):137-9. PubMed ID: 11757212
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.